Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

STAA

Staar Surgical Co.

May 10 • 04:00PM ET

42.35

Dollar change -0.51
Percentage change -1.19	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IJR VTI IWM VB VXF VBK IWO IJT SCHA IJS

Index	RUT	P/E	136.92	EPS (ttm)	0.31	Insider Own	0.78%	Shs Outstand	48.84M	Perf Week	-6.94%
Market Cap	2.08B	Forward P/E	50.86	EPS next Y	0.83	Insider Trans	183.45%	Shs Float	48.75M	Perf Month	-17.93%
Income	15.30M	PEG	4.56	EPS next Q	0.22	Inst Own	99.45%	Short Float	9.08%	Perf Quarter	40.42%
Sales	326.24M	P/S	6.38	EPS this Y	-36.51%	Inst Trans	1.94%	Short Ratio	6.27	Perf Half Y	25.41%
Book/sh	8.00	P/B	5.30	EPS next Y	29.86%	ROA	3.36%	Short Interest	4.43M	Perf Year	-37.37%
Cash/sh	4.99	P/C	8.49	EPS next 5Y	30.00%	ROE	4.18%	52W Range	26.66 - 68.27	Perf YTD	35.69%
Dividend Est.	-	P/FCF	99.65	EPS past 5Y	31.51%	ROI	3.61%	52W High	-37.97%	Beta	0.67
Dividend TTM	-	Quick Ratio	5.22	Sales past 5Y	21.55%	Gross Margin	78.51%	52W Low	58.88%	ATR (14)	2.23
Dividend Ex-Date	-	Current Ratio	5.84	EPS Y/Y TTM	-52.52%	Oper. Margin	7.05%	RSI (14)	43.25	Volatility	5.82% 4.33%
Employees	1115	Debt/Eq	0.09	Sales Y/Y TTM	10.70%	Profit Margin	4.69%	Recom	1.92	Target Price	51.50
Option/Short	Yes / Yes	LT Debt/Eq	0.08	EPS Q/Q	-224.64%	Payout	0.00%	Rel Volume	0.62	Prev Close	42.86
Sales Surprise	2.68%	EPS Surprise	74.84%	Sales Q/Q	5.21%	Earnings	May 07 AMC	Avg Volume	706.53K	Price	42.35
SMA20	-8.35%	SMA50	0.30%	SMA200	10.43%	Trades		Volume	440,889	Change	-1.19%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-11-24	Upgrade	Stifel	Hold → Buy	$30 → $50
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$35
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold	$77 → $48
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral	$65
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy	$80 → $67
Dec-08-22	Initiated	Stifel	Hold	$60
Nov-07-22	Upgrade	Sidoti	Neutral → Buy
Oct-14-22	Resumed	Stephens	Overweight	$91
Oct-13-22	Initiated	Mizuho	Buy	$85
Apr-08-22	Initiated	Needham	Buy	$87
Mar-28-22	Upgrade	The Benchmark Company	Hold → Buy	$97
Mar-18-22	Upgrade	BTIG Research	Neutral → Buy	$98
Jul-09-21	Initiated	Oppenheimer	Perform	$150
Jan-19-21	Downgrade	The Benchmark Company	Buy → Hold
Oct-26-20	Downgrade	Sidoti	Buy → Neutral
Aug-31-20	Upgrade	Sidoti	Neutral → Buy	$58

Show Previous Ratings

May-08-24 11:06AM	STAAR Surgical Company (NASDAQ:STAA) Q1 2024 Earnings Call Transcript (Insider Monkey) -12.07%
10:17AM	Mizuho Adjusts STAAR Surgical's Price Target to $55 From $53, Keeps Buy Rating (MT Newswires)
07:59AM	Morgan Stanley Raises Price Target on STAAR Surgical to $50 From $35, Keeps Equalweight Rating (MT Newswires)
03:43AM	Staar Surgical Co (STAA) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ... (GuruFocus.com)
May-07-24 11:54PM	STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:30PM	Loading…
07:30PM	Staar Surgical (STAA) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:58PM	Staar Surgical Co Reports Q1 2024 Results: Misses Earnings Projections Despite Revenue Growth (GuruFocus.com)
05:26PM	Staar Surgical: Q1 Earnings Snapshot (Associated Press Finance)
04:03PM	STAAR Surgical Reports First Quarter 2024 Results (Business Wire)
04:01PM	STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision (Business Wire)
May-06-24 09:16AM	Wall Street's Insights Into Key Metrics Ahead of Staar Surgical (STAA) Q1 Earnings (Zacks)
May-01-24 07:00AM	STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel (Business Wire)
Apr-29-24 07:00AM	STAAR Surgical to Report First Quarter Results on May 7, 2024 (Business Wire)
Apr-25-24 03:43PM	Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating (Investor's Business Daily)
Apr-05-24 09:15AM	Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength? (Zacks) +6.97%
04:26PM	Loading…
Apr-04-24 04:26PM	Staar Surgical, A Lasik Rival, Just Crushed Quarterly Views; But Is Its 2026 Target Too Aggressive? (Investor's Business Daily) +16.48%
03:54PM	Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus (Benzinga)
07:00AM	STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024 (Business Wire)
Apr-02-24 07:00AM	STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024 (Business Wire)
Mar-26-24 11:45AM	Nvidias Market Cap Myopia: 3 Stocks Proving Size Isnt Everything (InvestorPlace)
Mar-20-24 04:22AM	STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses (PR Newswire)
Mar-18-24 07:00AM	STAAR Surgical Celebrates Three Million Implantable Collamer Lenses (Business Wire)
Mar-12-24 10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
07:00AM	STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors (Business Wire)
Mar-06-24 07:00AM	STAAR Surgical to Participate in Two Upcoming Investor Conferences (Business Wire) +6.67%
Feb-28-24 10:58AM	STAAR Surgical Company (NASDAQ:STAA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 02:00PM	Staar Surgical (STAA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
Feb-26-24 05:30PM	Staar Surgical (STAA) Beats Q4 Earnings Estimates (Zacks)
04:39PM	Staar Surgical: Q4 Earnings Snapshot (Associated Press Finance)
04:34PM	Staar Surgical Co (STAA) Posts Solid Growth in Q4 and FY 2023, Affirms Positive Outlook for 2024 (GuruFocus.com)
04:01PM	Loading…
04:01PM	STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results (Business Wire)
Feb-19-24 07:00AM	STAAR Surgical to Report Fourth Quarter Results on February 26, 2024 (Business Wire)
Jan-27-24 01:03PM	Baillie Gifford Adjusts Position in Staar Surgical Co (GuruFocus.com)
Jan-23-24 07:00AM	STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision (Business Wire)
Jan-12-24 06:49PM	Howard Hughes, Carrier, and More Stocks See Action From Activist Investors (Barrons.com)
Jan-08-24 07:00AM	STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023 (Business Wire) +11.52%
Dec-17-23 12:35PM	7 Stocks with Strong Insider Buying: December 2023 (InvestorPlace)
Dec-05-23 03:16AM	Lululemon Athletica gets one more downgrade ahead of Q3 report: 4 big analyst cuts (Investing.com)
Dec-04-23 04:05PM	Lilian Zhou Appointed to STAAR Surgical Board of Directors (Business Wire)
Nov-15-23 07:00AM	STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023) (Business Wire)
Nov-02-23 05:50PM	STAAR Surgical Company (NASDAQ:STAA) Q3 2023 Earnings Call Transcript (Insider Monkey) -16.87%
09:23AM	Q3 2023 STAAR Surgical Co Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 06:30PM	Here's What Key Metrics Tell Us About Staar Surgical (STAA) Q3 Earnings (Zacks)
05:56PM	Staar Surgical Co (STAA) Reports 6% Y/Y Increase in Q3 2023 Net Sales (GuruFocus.com)
04:17PM	Staar Surgical: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Third Quarter 2023 Results (Business Wire)
Oct-31-23 04:40PM	Investor urges STAAR Surgical to spin off Asia unit - letter (Reuters)
Oct-18-23 04:05PM	STAAR Surgical to Report Third Quarter Results on November 1, 2023 (Business Wire)
Oct-17-23 07:00AM	STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer Lens (ICL) (Business Wire)
Oct-13-23 06:30PM	Staar Surgical, Howard Hughes Holdings, and More Stocks See Action From Activist Investors (Barrons.com)
Oct-10-23 10:51AM	Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL (PR Newswire)
Sep-19-23 11:51AM	Is Staar Surgical Co (STAA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
Sep-15-23 09:32AM	Shake Shack upgraded, DoorDash downgraded: Wall Street's top analyst calls (The Fly)
Sep-14-23 12:53PM	Is Staar Surgical Co (STAA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
07:00AM	STAAR Surgical to Ring Nasdaq Stock Market Closing Bell Following Vision 2026 Investor Day on September 14, 2023 (Business Wire)
Sep-08-23 11:38AM	Staar Surgical Co (STAA): A Potential Value Trap? (GuruFocus.com)
Sep-07-23 05:00PM	STAAR Surgical to Host "Vision 2026" Investor Day on September 14, 2023 (Business Wire)
Aug-18-23 10:40AM	Dolby Labs jumps as S&P prepares to add it to its MidCap 400 index (Investing.com)
Aug-17-23 06:48PM	Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600 (PR Newswire)
Aug-09-23 07:00AM	STAAR Surgical Teams Up With Tennessee Titans Quarterback Will Levis On Life Changing Vision Correction Procedure, EVO ICL (Business Wire)
Aug-07-23 07:00AM	STAAR Surgical to Participate in Upcoming Investor Conferences (Business Wire)
05:00AM	3 Strong Buy Growth Stocks You Should Be Loading Up On Now (InvestorPlace)
Aug-03-23 07:18PM	Why STAAR Surgical Stock Dropped Today (Motley Fool) -9.60%
Aug-02-23 05:25PM	Staar Surgical (STAA) Q2 Earnings Beat Estimates (Zacks)
04:21PM	Staar Surgical: Q2 Earnings Snapshot (AP Finance)
04:01PM	STAAR Surgical Reports Second Quarter 2023 Results (Business Wire)
Jul-19-23 07:00AM	STAAR Surgical to Report Second Quarter Results on August 2, 2023 (Business Wire)
Jun-21-23 08:00PM	STAA: Rating increased to a HOLD (Argus Research)
Jun-13-23 08:00AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
May-26-23 06:00AM	STAAR Surgical Company (NASDAQ:STAA) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? (Simply Wall St.)
May-17-23 10:10AM	2 Stocks With Unstoppable Growth Potential for the Next Decade (Motley Fool)
May-09-23 01:48PM	STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue (Simply Wall St.)
May-04-23 07:00AM	EVO ICL Sponsors Jonas Brothers The Tour (Business Wire) -7.78%
May-03-23 05:35PM	Staar Surgical (STAA) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:29PM	Staar Surgical: Q1 Earnings Snapshot (AP Finance)
04:01PM	STAAR Surgical Reports First Quarter 2023 Results (Business Wire)
Apr-27-23 10:02AM	Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-26-23 08:00PM	STAA: Lowering target price to $54.00 (Argus Research)
10:02AM	Earnings Preview: Staar Surgical (STAA) Q1 Earnings Expected to Decline (Zacks)
Apr-23-23 08:25AM	Should You Think About Buying STAAR Surgical Company (NASDAQ:STAA) Now? (Simply Wall St.)
Apr-19-23 07:00AM	STAAR Surgical to Report First Quarter Results on May 3, 2023 (Business Wire)
Apr-07-23 11:44AM	STAAR Surgical's (NASDAQ:STAA) investors will be pleased with their incredible 346% return over the last five years (Simply Wall St.)
Apr-04-23 06:00PM	Staar Surgical (STAA) Gains As Market Dips: What You Should Know (Zacks)
Mar-29-23 06:00PM	Staar Surgical (STAA) Stock Sinks As Market Gains: What You Should Know (Zacks)
07:00AM	STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer (Business Wire)
Mar-23-23 06:00PM	Staar Surgical (STAA) Outpaces Stock Market Gains: What You Should Know (Zacks)
Mar-15-23 05:50PM	Staar Surgical (STAA) Dips More Than Broader Markets: What You Should Know (Zacks)
Mar-13-23 08:48AM	Implied Volatility Surging for STAAR Surgical (STAA) Stock Options (Zacks)
Mar-09-23 05:25AM	Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA) (Simply Wall St.)
Feb-23-23 05:12AM	STAAR Surgical Full Year 2022 Earnings: EPS: US$0.81 (vs US$0.52 in FY 2021) (Simply Wall St.)
Feb-21-23 05:15PM	Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates (Zacks)
04:01PM	STAAR Surgical Reports Fourth Quarter and Fiscal Year 2022 Results (Business Wire)
Feb-13-23 05:50PM	Staar Surgical (STAA) Outpaces Stock Market Gains: What You Should Know (Zacks)
Feb-07-23 07:00AM	STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023 (Business Wire)
Feb-03-23 05:50PM	Staar Surgical (STAA) Dips More Than Broader Markets: What You Should Know (Zacks)
01:58PM	STAAR Surgical (STAA) to Report Q4 Earnings: What's in Store? (Zacks)
09:00AM	STAAR Surgical Company (STAA) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jan-31-23 09:25AM	15 Largest Ophthalmology Companies in the World (Insider Monkey)
Jan-25-23 06:00PM	Staar Surgical (STAA) Gains As Market Dips: What You Should Know (Zacks)
Jan-24-23 03:26PM	Analyst Reiterates This Ophthalmology Device Stock On Steep But Attractive Risk/Reward (Benzinga) -5.12%

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WEISNER AIMEE S	Director	Mar 14 '24	Buy	38.11	1,750	66,692	10,864	Mar 14 05:23 PM
Williams Patrick F.	Chief Financial Officer	Mar 07 '24	Option Exercise	0.00	2,614	0	45,475	Mar 11 06:06 AM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 08 '24	Buy	27.11	4,042	109,570	10,768,430	Jan 10 05:44 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 05 '24	Buy	28.48	156,734	4,463,231	10,764,388	Jan 05 07:07 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 04 '24	Buy	28.91	63,246	1,828,183	10,607,654	Jan 05 07:07 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 03 '24	Buy	28.93	6,573	190,144	10,544,408	Jan 05 07:07 PM
Zhou Lilian Yansheng	Director	Dec 06 '23	Buy	30.74	850	26,129	2,327	Dec 06 04:11 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 30 '23	Buy	31.42	177,707	5,583,678	10,537,835	Nov 30 07:08 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 29 '23	Buy	31.39	160,300	5,031,358	10,360,128	Nov 30 07:08 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 28 '23	Buy	31.85	96,984	3,088,794	10,199,828	Nov 30 07:08 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 13 '23	Buy	33.04	507	16,749	10,102,844	Nov 14 07:13 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 10 '23	Buy	32.73	34,320	1,123,383	10,102,337	Nov 14 07:13 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 09 '23	Buy	33.09	140,000	4,632,581	10,068,017	Nov 09 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 08 '23	Buy	33.71	139,409	4,699,073	9,928,017	Nov 09 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 07 '23	Buy	34.03	9,731	331,127	9,788,608	Nov 09 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 06 '23	Buy	34.16	164,607	5,623,518	9,778,877	Nov 06 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 03 '23	Buy	36.06	520	18,753	9,614,270	Nov 06 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 02 '23	Buy	35.79	144,027	5,155,243	9,613,750	Nov 06 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Oct 06 '23	Buy	37.62	75,299	2,832,417	9,469,723	Oct 06 07:43 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Oct 05 '23	Buy	37.92	97,474	3,696,399	9,394,424	Oct 06 07:43 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Oct 04 '23	Buy	37.93	32,523	1,233,649	9,296,950	Oct 06 07:43 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Sep 21 '23	Buy	39.62	154,814	6,133,467	9,264,427	Sep 21 08:31 PM
Lin Elizabeth Yeu	Director	Sep 21 '23	Buy	40.00	2,500	100,000	2,855	Sep 22 07:18 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Sep 20 '23	Buy	40.67	132,079	5,372,274	9,109,613	Sep 21 08:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Sep 19 '23	Buy	40.89	4,490	183,613	8,977,534	Sep 21 08:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Sep 07 '23	Buy	41.26	60,874	2,511,722	8,973,044	Sep 07 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Sep 06 '23	Buy	41.43	108,944	4,513,735	8,912,170	Sep 07 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Sep 05 '23	Buy	41.87	20,144	843,455	8,803,226	Sep 07 07:00 PM
Williams Patrick F.	Chief Financial Officer	Aug 10 '23	Option Exercise	0.00	5,122	0	45,400	Aug 11 06:01 PM
WEISNER AIMEE S	Director	Aug 07 '23	Buy	48.72	2,000	97,440	5,417	Aug 07 04:16 PM
Kliman Gilbert H	Director	Jun 15 '23	Option Exercise	0.00	3,417	0	9,656	Jun 16 08:39 PM
WEISNER AIMEE S	Director	Jun 15 '23	Option Exercise	0.00	3,417	0	3,417	Jun 16 08:37 PM
Yu K Peony	Director	Jun 15 '23	Option Exercise	0.00	1,709	0	2,786	Jun 16 08:35 PM
FARRELL STEPHEN C	Director	Jun 15 '23	Option Exercise	0.00	1,709	0	8,276	Jun 16 08:41 PM
Williams Patrick F.	Chief Financial Officer	Jun 06 '23	Option Exercise	0.00	5,121	0	47,387	Jun 07 04:53 PM

Open in Screener

TARS

Tarsus Pharmaceuticals Inc

May 10 • 04:00PM ET

37.00

Dollar change +2.96
Percentage change 8.70	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

TARS Tarsus Pharmaceuticals Inc daily Stock Chart

Held by: VTI IWM VXF IWN IBB SCHA VTWO VHT IHE IWC

Index	RUT	P/E	-	EPS (ttm)	-4.77	Insider Own	19.42%	Shs Outstand	34.21M	Perf Week	0.41%
Market Cap	1.40B	Forward P/E	-	EPS next Y	-1.51	Insider Trans	-1.38%	Shs Float	30.45M	Perf Month	-3.37%
Income	-148.21M	PEG	-	EPS next Q	-0.93	Inst Own	80.45%	Short Float	25.16%	Perf Quarter	18.78%
Sales	42.56M	P/S	32.84	EPS this Y	20.37%	Inst Trans	1.80%	Short Ratio	10.74	Perf Half Y	123.70%
Book/sh	7.29	P/B	5.08	EPS next Y	58.84%	ROA	-52.88%	Short Interest	7.66M	Perf Year	121.56%
Cash/sh	7.90	P/C	4.68	EPS next 5Y	-	ROE	-66.07%	52W Range	12.57 - 42.50	Perf YTD	82.72%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-132.82%	ROI	-48.57%	52W High	-12.94%	Beta	1.12
Dividend TTM	-	Quick Ratio	7.92	Sales past 5Y	-17.43%	Gross Margin	90.76%	52W Low	194.35%	ATR (14)	2.51
Dividend Ex-Date	-	Current Ratio	8.01	EPS Y/Y TTM	-93.69%	Oper. Margin	-366.27%	RSI (14)	57.48	Volatility	10.16% 6.92%
Employees	244	Debt/Eq	0.11	Sales Y/Y TTM	53.22%	Profit Margin	-348.22%	Recom	1.33	Target Price	55.67
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	-15.59%	Payout	-	Rel Volume	1.14	Prev Close	34.04
Sales Surprise	54.32%	EPS Surprise	14.47%	Sales Q/Q	1004.56%	Earnings	May 08 AMC	Avg Volume	712.94K	Price	37.00
SMA20	8.39%	SMA50	7.94%	SMA200	58.77%	Trades		Volume	811,275	Change	8.70%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-20-23	Initiated	Goldman	Neutral	$19
Jul-18-23	Initiated	William Blair	Outperform	$44
May-18-23	Initiated	Guggenheim	Buy
Aug-01-22	Initiated	Barclays	Overweight	$40
Dec-21-21	Initiated	H.C. Wainwright	Buy	$40
Nov-23-21	Initiated	Oppenheimer	Outperform	$55
Nov-10-20	Initiated	Raymond James	Strong Buy	$39
Nov-10-20	Initiated	Ladenburg Thalmann	Buy	$42
Nov-10-20	Initiated	Jefferies	Buy	$35
Nov-10-20	Initiated	BofA Securities	Buy	$33

May-09-24 05:00PM	Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference (GlobeNewswire) -8.86%
12:48PM	Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:06AM	Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating (MT Newswires)
03:49AM	Tarsus Pharmaceuticals Inc (TARS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ... (GuruFocus.com)
May-08-24 08:58PM	TARS Stock Earnings: Tarsus Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:40PM	Loading…
05:40PM	Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements (GlobeNewswire)
May-06-24 09:55AM	Does Tarsus Pharmaceuticals (TARS) Have the Potential to Rally 38.7% as Wall Street Analysts Expect? (Zacks)
May-01-24 05:00PM	Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (GlobeNewswire)
Apr-23-24 08:30AM	Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon (GlobeNewswire)
Apr-09-24 07:35AM	5 Best Biotech ETFs To Buy (Insider Monkey)
Apr-08-24 09:55AM	Wall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know (Zacks)
Apr-04-24 11:33AM	Aggressive Stock Portfolio: 13 Stocks Picked by Analysts (Insider Monkey)
Apr-01-24 12:00PM	Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why (Zacks)
Mar-06-24 09:55AM	How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91% (Zacks)
04:30PM	Loading…
Mar-05-24 04:30PM	Tarsus to Participate at Upcoming Investor Conferences (GlobeNewswire)
08:30AM	Tarsus Introduces Mite Party Campaign for XDEMVY (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis (GlobeNewswire)
Mar-01-24 12:07AM	Tarsus Announces Pricing of $100.0 Million Public Offering (GlobeNewswire)
Feb-29-24 04:37PM	Tarsus Announces Proposed $100.0 Million Public Offering (GlobeNewswire)
Feb-28-24 12:00PM	Here's Why Tarsus Pharmaceuticals, Inc. (TARS) is a Great Momentum Stock to Buy (Zacks)
09:58AM	Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 11:13PM	Q4 2023 Tarsus Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +18.28%
06:34AM	Tarsus Pharmaceuticals Inc (TARS) Reports Robust Q4 and Full-Year 2023 Financial Results (GuruFocus.com)
06:00AM	Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements (GlobeNewswire)
Feb-22-24 08:00AM	Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept Tick-Kill Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease (GlobeNewswire)
Feb-20-24 05:00PM	Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024 (GlobeNewswire)
Jan-31-24 05:00PM	Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference (GlobeNewswire)
Jan-30-24 04:06AM	Tarsus Pharmaceuticals, Inc. (TARS) Moves 8.5% Higher: Will This Strength Last? (Zacks)
Jan-21-24 07:01AM	11 Stocks That Will Make You Rich in 5-10 Years (Insider Monkey)
Dec-21-23 03:32PM	Tarsus Pharmaceuticals Stock Scores Relative Strength Rating Upgrade (Investor's Business Daily)
08:00AM	Loading…
Dec-11-23 08:00AM	Tarsus Announces Positive Topline Results from the Ersa Phase 2a Clinical Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease in Patients with Demodex Mites (GlobeNewswire)
Dec-01-23 11:04PM	Insider Sell Alert: Tarsus Pharmaceuticals Inc's Dianne Whitfield Offloads 8,355 Shares (GuruFocus.com)
Nov-12-23 12:15PM	Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:05PM	Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements (GlobeNewswire) -5.86%
Nov-01-23 06:35PM	Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 (GlobeNewswire)
Sep-06-23 08:00AM	Tarsus to Ring Nasdaq Stock Market Closing Bell in Celebration of the Launch of XDEMVY, the First and Only FDA Approved Treatment for Demodex Blepharitis (GlobeNewswire)
Aug-30-23 04:30PM	Tarsus to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-28-23 10:22AM	15 Most Shorted Stocks That Are Loved By Analysts (Insider Monkey)
Aug-24-23 09:00AM	Now Available XDEMVY (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis (GlobeNewswire)
Aug-10-23 04:05PM	Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements (GlobeNewswire)
Aug-03-23 02:14PM	This Tarsus Pharmaceuticals Insider Increased Their Holding In The Last Year (Simply Wall St.)
Aug-01-23 10:30PM	Tarsus Announces Pricing of $100.0 Million Underwritten Public Offering of Common Stock (GlobeNewswire) -16.99%
Jul-31-23 04:29PM	Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of Shares of its Common Stock (GlobeNewswire)
Jul-25-23 07:00AM	FDA Approves XDEMVY (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis (GlobeNewswire) -24.82%
Jul-20-23 02:04PM	Why Shares of Tarsus Pharmaceuticals Are Up Thursday (Motley Fool) +15.56%
Jul-19-23 08:34PM	Tarsus Pharmaceuticals, Inc. (TARS) Surges 7.8%: Is This an Indication of Further Gains? (Zacks) +7.83%
10:13AM	Oppenheimer Says These 2 Stocks Could Double Your Money Heres Why They Could Jump (TipRanks)
Jun-12-23 08:30AM	Tarsus to Host Virtual Investor Webcast Highlighting the Commercialization Strategy, Plans and Progress for TP-03, Its Potential Treatment for Demodex Blepharitis (GlobeNewswire)
Jun-05-23 08:30AM	Tarsus to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-09-23 04:05PM	Tarsus Reports First Quarter 2023 Financial Results and Recent Business Achievements (GlobeNewswire)
May-08-23 08:30AM	Tarsus Launches Dont Freak Out. Get Checked Out. Campaign During Healthy Vision Month to Encourage Patients with Demodex Blepharitis to Visit Eye Care Providers (GlobeNewswire)
May-05-23 08:22AM	Shareholders Should Be Pleased With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Price (Simply Wall St.)
May-03-23 04:30PM	Tarsus to Participate at the Bank of America 2023 Healthcare Conference (GlobeNewswire)
Apr-24-23 08:30AM	Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer (GlobeNewswire)
Apr-18-23 06:04AM	Tarsus Pharmaceuticals, Inc. (TARS) Soars 8.6%: Is Further Upside Left in the Stock? (Zacks) +5.25%
Apr-06-23 03:52PM	Shareholders in Tarsus Pharmaceuticals (NASDAQ:TARS) are in the red if they invested a year ago (Simply Wall St.)
Mar-17-23 06:28AM	Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Is Expected To Breakeven In The Near Future (Simply Wall St.)
Mar-13-23 04:05PM	Tarsus Reports Full-Year 2022 Financial Results and Recent Business Achievements (GlobeNewswire)
Mar-09-23 10:00AM	Will Provention Bio, Inc. (PRVB) Report Negative Earnings Next Week? What You Should Know (Zacks)
Mar-02-23 04:30PM	Tarsus to Present at Upcoming Investor Conferences (GlobeNewswire)
Feb-24-23 11:44AM	Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) insiders placed bullish bets worth US$1.6m in the last 12 months (Simply Wall St.)
Jan-24-23 04:33AM	Strength Seen in Tarsus Pharmaceuticals, Inc. (TARS): Can Its 5.0% Jump Turn into More Strength? (Zacks)
Dec-16-22 07:00AM	Tarsus Added to NASDAQ Biotechnology Index (GlobeNewswire)
Dec-15-22 12:45PM	Tarsus Pharma Touts Positive Data For Experimental Drug For Tick-Borne Disease (Benzinga)
08:30AM	Tarsus Announces Positive Topline Data from Phase 1b Callisto Trial and Initiates Phase 2a Carpo Human Tick Kill Trial Evaluating TP-05, A Novel, Oral Therapeutic for the Prevention of Lyme Disease (GlobeNewswire)
Dec-08-22 06:55AM	Institutional investors own a significant stake of 41% in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) (Simply Wall St.)
Nov-11-22 06:03AM	Tarsus Pharmaceuticals Third Quarter 2022 Earnings: US$0.84 loss per share (vs US$0.76 loss in 3Q 2021) (Simply Wall St.)
Nov-09-22 08:45AM	Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Tarsus Reports Third Quarter 2022 Financial Results and Recent Business Achievements (GlobeNewswire)
Oct-25-22 08:30AM	Tarsus to Present Additional Saturn-2 Pivotal Phase 3 Trial Data at the American Academy of Optometry 2022 Annual Meeting (GlobeNewswire)
Oct-17-22 09:26AM	Tarsus Pharmaceuticals (NASDAQ:TARS) investors are sitting on a loss of 40% if they invested a year ago (Simply Wall St.)
Oct-11-22 08:30AM	Tarsus Announces Transition Plans for Board of Directors (GlobeNewswire)
Oct-06-22 08:30AM	Tarsus Appoints Scott Morrison as Board Member and Audit Committee Chair (GlobeNewswire)
Sep-29-22 08:30AM	Tarsus Launches Look at the Lids Campaign to Encourage Eye Care Professionals to Identify and Diagnose Demodex Blepharitis (GlobeNewswire)
Sep-27-22 12:00PM	Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings (GlobeNewswire)
Sep-17-22 10:23AM	The Chief Medical Advisor & Director of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), Elizabeth Lin, Just Bought A Few More Shares (Simply Wall St.)
Sep-07-22 07:00AM	Tarsus Submits New Drug Application to the FDA for TP-03 for the Treatment of Demodex Blepharitis (GlobeNewswire)
Aug-11-22 05:25PM	Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Tarsus Reports Second Quarter 2022 Financial Results and Recent Business Achievements (GlobeNewswire)
Aug-05-22 08:30AM	Tarsus Initiates Phase 2a Ersa Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease (GlobeNewswire)
Jul-25-22 08:00AM	Certara Appoints Rosemary Crane as New Independent Board Member (GlobeNewswire)
Jun-29-22 06:51AM	Do Insiders Own Lots Of Shares In Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)? (Simply Wall St.)
May-27-22 09:00AM	Tarsus to Present at the Jefferies 2022 Healthcare Conference (GlobeNewswire)
May-14-22 08:19AM	Analysts Just Shipped A Captivating Upgrade To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Estimates (Simply Wall St.)
May-11-22 06:30AM	The Co-Founder & Independent Chairperson of the Board of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), D. Ackermann, Just Bought 8.3% More Shares (Simply Wall St.)
May-10-22 06:55PM	Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +11.30%
04:05PM	Tarsus Reports First Quarter 2022 Financial Results and Recent Business Achievements (GlobeNewswire)
May-09-22 01:49PM	Further weakness as Tarsus Pharmaceuticals (NASDAQ:TARS) drops 39% this week, taking one-year losses to 63% (Simply Wall St.)
May-06-22 09:00AM	Tarsus to Present at Bank of America 2022 Healthcare Conference (GlobeNewswire) -8.05%
May-05-22 08:30AM	Tarsus Presents New Findings from Two Studies Demonstrating the Impact of Demodex Blepharitis at the ARVO 2022 Annual Meeting (GlobeNewswire) -6.73%
May-03-22 03:00PM	Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks) -6.79%
06:58AM	Tarsus Announces Pricing of Upsized $75.6 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
May-02-22 07:01AM	Tarsus Announces Proposed $50 Million Underwritten Public Offering of Shares of its Common Stock (GlobeNewswire) -23.54%
07:00AM	Tarsus Announces Positive Topline Data from Saturn-2 Phase 3, the Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis, and Expects to File a New Drug Application This Year (GlobeNewswire)
Apr-29-22 09:23PM	Tarsus to Host Webcast to Review Topline Results from Saturn-2 Phase 3, the Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis (GlobeNewswire)
Apr-26-22 08:30AM	Tarsus Presents Results of Two Studies Highlighting Demodex Blepharitis Patient Impact and Burden at the ASCRS 2022 Annual Meeting (GlobeNewswire)
Apr-21-22 03:05AM	E3 Metals Initiates Design of Field Pilot (PR Newswire)
Mar-14-22 04:05PM	Tarsus Pharmaceuticals, Inc. Reports Full-Year 2021 Financial Results and Recent Business Achievements (GlobeNewswire) -5.90%
Mar-09-22 05:00PM	Tarsus to Present at Upcoming Investor Conferences (GlobeNewswire)
Feb-03-22 09:00AM	Tarsus Expands Executive Leadership Team with the Appointment of José Trevejo, M.D., Ph.D., as Chief Medical Officer (GlobeNewswire)

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Azamian Bobak R.	President/CEO and Board Chair	Mar 18 '24	Sale	30.60	10,415	318,699	26,456	Mar 19 07:05 PM
Neervannan Seshadri	Chief Operating Officer	Mar 18 '24	Sale	30.60	4,879	149,297	64,767	Mar 19 07:03 PM
Mottiwala Aziz	Chief Commercial Officer	Mar 18 '24	Sale	30.60	4,766	145,840	54,075	Mar 19 07:08 PM
Wahl Bryan	General Counsel	Mar 18 '24	Sale	30.60	4,436	135,742	40,951	Mar 19 07:05 PM
Whitfield Dianne C.	Chief Human Resources Officer	Mar 18 '24	Sale	30.60	4,314	132,008	34,181	Mar 19 07:04 PM
Azamian Bobak R.	President/CEO and Board Chair	Dec 27 '23	Sale	20.22	8,000	161,760	830,106	Dec 29 05:08 PM
Azamian Bobak R.	President/CEO and Board Chair	Dec 20 '23	Sale	20.27	40,000	810,623	838,106	Dec 22 05:30 PM
Trevejo Jose M.	CHIEF MEDICAL OFFICER	Dec 20 '23	Sale	20.00	2,252	45,040	2,251	Dec 22 05:32 PM
Goldberg Andrew D.	Director	Dec 15 '23	Buy	18.96	1,000	18,960	3,000	Dec 19 06:30 PM
Wahl Bryan	General Counsel	Nov 30 '23	Sale	16.31	8,356	136,286	31,966	Dec 01 04:55 PM
Whitfield Dianne C.	Chief Human Resources Officer	Nov 30 '23	Sale	16.31	8,355	136,270	26,784	Dec 01 04:58 PM
Whitfield Dianne C.	Chief Human Resources Officer	Nov 29 '23	Option Exercise	0.00	23,920	0	35,139	Dec 01 04:58 PM
Wahl Bryan	General Counsel	Nov 29 '23	Option Exercise	0.00	23,920	0	40,322	Dec 01 04:55 PM
Azamian Bobak R.	President/CEO and Board Chair	Nov 15 '23	Sale	18.37	8,000	146,933	878,106	Nov 17 04:50 PM
Azamian Bobak R.	President/CEO and Board Chair	Oct 18 '23	Sale	13.24	8,000	105,920	886,106	Oct 20 04:41 PM
Trevejo Jose M.	CHIEF MEDICAL OFFICER	Oct 05 '23	Sale	18.00	1,604	28,872	4,503	Oct 06 05:21 PM
Azamian Bobak R.	President/CEO and Board Chair	Sep 20 '23	Sale	17.21	8,000	137,680	894,106	Sep 22 05:30 PM
Azamian Bobak R.	President/CEO and Board Chair	Aug 23 '23	Sale	17.23	8,000	137,840	902,106	Aug 25 05:12 PM
Lin Elizabeth Yeu	Director	Aug 15 '23	Buy	16.80	9,506	159,701	15,866	Aug 17 06:02 PM
Azamian Bobak R.	President/CEO and Board Chair	Jul 19 '23	Sale	20.01	103,900	2,078,984	910,106	Jul 21 05:42 PM
Mottiwala Aziz	Chief Commercial Officer	Jul 19 '23	Sale	20.05	2,400	48,120	45,806	Jul 21 05:46 PM
Azamian Bobak R.	President/CEO and Board Chair	Jul 12 '23	Sale	17.35	9,000	156,150	1,014,006	Jul 14 04:40 PM
Azamian Bobak R.	President/CEO and Board Chair	Jun 21 '23	Sale	18.63	8,000	149,040	1,023,006	Jun 23 04:29 PM
Azamian Bobak R.	President/CEO and Board Chair	Jun 14 '23	Sale	18.58	9,000	167,220	1,031,006	Jun 16 04:48 PM
Azamian Bobak R.	President/CEO and Board Chair	Jun 08 '23	Sale	20.01	3,100	62,031	1,040,006	Jun 12 05:40 PM
Mottiwala Aziz	Chief Commercial Officer	Jun 08 '23	Sale	20.00	100	2,000	48,086	Jun 12 05:25 PM
Mottiwala Aziz	Chief Commercial Officer	Jun 07 '23	Sale	19.34	2,500	48,350	48,186	Jun 08 07:16 PM
Mottiwala Aziz	Chief Commercial Officer	Jun 06 '23	Sale	18.61	2,143	39,881	50,686	Jun 08 07:16 PM
Azamian Bobak R.	President/CEO and Board Chair	May 17 '23	Sale	15.90	8,000	127,200	1,043,106	May 19 07:08 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

STAA

Staar Surgical Co.

TARS

Tarsus Pharmaceuticals Inc

Upgrade your FINVIZ experience